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Xylella fastidiosa is a Gram-negative xylem-limited plant pathogenic bacterium responsible for several
economically important crop diseases. Here, we present a novel and efﬁcient protein refolding protocol
for the solubilization and puriﬁcation of recombinant X. fastidiosa peptidoglycan-associated lipoprotein
(XfPal). Pal is an outer membrane protein that plays important roles in maintaining the integrity of
the cell envelope and in bacterial pathogenicity. Because Pal has a highly hydrophobic N-terminal
domain, the heterologous expression studies necessary for structural and functional protein characteriza-
tion are laborious once the recombinant protein is present in inclusion bodies. Our protocol based on the
denaturation of the XfPal-enriched inclusion bodies with 8 M urea followed by buffer-exchange steps via
dialysis proved effective for the solubilization and subsequent puriﬁcation of XfPal, allowing us to obtain
a large amount of relatively pure and folded protein. In addition, XfPal was biochemically and function-
ally characterized. The method for puriﬁcation reported herein is valuable for further research on the
three-dimensional structure and function of Pal and other outer membrane proteins and can contribute
to a better understanding of the role of these proteins in bacterial pathogenicity, especially with regard to
the plant pathogen X. fastidiosa.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The peptidoglycan-associated lipoprotein (Pal1) is an outer
membrane (OM) protein found in Gram-negative bacteria [1,2]. It
is anchored to the OM by an N-terminal lipid moiety and interacts
strongly with the peptidoglycan layer through its C-terminal
region [3], playing an important role in maintaining the integrity
of the cell envelope [3,4].
Several studies indicate a signiﬁcant role for Pal in the survival
and pathogenesis of certain bacteria, including Escherichia coli
[5,6], Aggregatibacter actinomycetemcomitans [7], Haemophilus
ducreyi [8], Erwinia chrysanthemi [9], Vibrio cholerae [10], and
Caulobacter crescentus [11]; however, its role in virulence is poorlyecular e Engenharia Genética
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sevier OA license.understood. In addition to its structural functions, Pal is highly
immunogenic and is considered a perfect antigen for the produc-
tion of vaccines [12,13].
Pal is a component of the Tol–Pal system [1] and interacts with
several factors involved in this system, including TolB and TolA,
and with cell envelope proteins, such as OmpA (outer membrane
protein A) and Lpp (lipoprotein) [1,14–16]. However, due to the
fact that Pal has a highly hydrophobic N-terminal domain and is
incorporated into inclusion bodies, the heterologous expression
studies necessary for structural and functional protein character-
ization are challenging. The principal protocol that is widely used
for the solubilization and puriﬁcation of native bacterial Pal is
based on the protocol described for the puriﬁcation of Pal from
Haemophilus inﬂuenzae (HiPal), also known as P6 [17]. However,
this protocol employs several steps involving ultracentrifugation,
the use of anionic detergents, and heat treatment with a ﬁnal
low yield of puriﬁed protein (approximately 0.5 mg per liter of bac-
terial culture [18]), which hinders the characterization of this
protein.
In the present work, we developed a novel and efﬁcient protocol
for the solubilization and puriﬁcation of recombinant Pal from
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Gram-negative xylem-limited plant pathogenic bacterium that is
responsible for several economically important plant diseases,
including citrus variegated chlorosis, phony peach disease, plum
leaf scald, Pierce’s disease of grapes, and leaf scorch of almond,
coffee, elm, oak, oleander, pear and sycamore [19,20]. The protocol
is based on the treatment of the XfPal-enriched inclusion bodies
with 8 M urea followed by buffer-exchange steps via dialysis, a
method that proved effective for the solubilization and subsequent
puriﬁcation of XfPal. We achieved a relatively pure protein yield of
greater than 17 mg per liter of bacterial culture. In addition, XfPal
was biochemically and functionally characterized. The goals of our
work are to encourage new studies focused on the structure and
function of this protein to provide further information about of
the relationship between Pal and bacterial pathogenesis.Materials and methods
Materials
The E. coli DH5-a strain was used as the host strain for cloning,
and the E. coli BL21 (DE3) strain (Novagen; USA) was the host
strain for the heterologous protein expression. The E. coli JW0731
strain [21] was used for the peptidoglycan extraction. The oligonu-
cleotides primers were synthesized by Sinapse Technologies
(Brazil). The pET29a(+) expression vector was obtained from
Novagen (USA). The NdeI and XhoI restriction enzymes were
purchased from New England Biolabs (UK). The protease inhibitor
phenylmethanesulfonyl ﬂuoride (PMSF) and lysozyme were
obtained from Sigma Chemical (USA). The urea reagent used for
protein refolding was acquired from GE Healthcare (Sweden). The
Ni–NTA afﬁnity resin was obtained from Qiagen (Germany). The
molecular mass marker (LMW and HMW) and the Superdex 75
10/300 GL chromatography column were purchased from GE
Healthcare (Sweden). The total protein concentration was deter-
mined using a micro BCA™ protein assay kit (Thermo Scientiﬁc;
USA). All other chemicals used were of biochemical research grade.
Alignment of XfPal with H. inﬂuenzae (HiPal)
The HiPal (GenBank accession number: AAX87436.1) and XfPal
(GenBank accession number: AAF84702.1) precursor amino acid
sequences were obtained from the NCBI databank (www.ncbi.nih.-
gov) and aligned using ClustalW2 (http://www.ebi.ac.uk/Tools/clu-
stalw2/index.html). Further editingwas performed using GENEDOC
software [22].
XfPal cloning and overexpression
The sequence of themature XfPal proteinwas obtained from the
X. fastidiosa comparative database (http://www.xylella.lncc.br/).
The coding sequence of the xfpal gene (ORF Xf1624; 432 bp) was
ampliﬁed by PCR from X. fastidiosa (9a5c strain) genomic DNA using
the speciﬁc oligonucleotides Xf1624F (50-CTAATCATATGGCACCAA
CTGTTTCTAC-30) and Xf1624R (50-AAACTCGAGCTTCGCTGTATAGA
CG-30), which containedNdeI and XhoI restriction sites, respectively.
The PCR ampliﬁcation product was cloned into the pET29a(+)
(Novagen; USA) expression vector, which added a C-terminal
six-histidine tag to the coding sequence. The presence of base sub-
stitutions in the recombinant plasmid was assessed by DNA
sequencing. XfPal was overexpressed in the E. coli BL21 (DE3) strain.
The cells were grown at 37 C with shaking at 300 rpm in 1 L of LB
broth containing kanamycin (30 lg/mL) until an OD600 of 0.6–0.8
was reached. The expression of the recombinant protein was in-
duced by the addition of 5.6 mM lactose, followed by cultivationfor 4 h at 37 C and 300 rpm. The culturewas harvested by centrifu-
gation (3000g for 15 min at 4 C), and the cell pellets (approximately
3 g wet weight) were resuspended in 50 mL of buffer A (50 mM
Tris–HCl pH 8 and 300 mM NaCl) plus 1 mg/mL lysozyme and
1 mM PMSF and were incubated for 30 min on ice. The cells were
disrupted by sonication, and the insoluble fraction was collected
by centrifugation (27,000g for 40 min at 4 C).
Protein refolding and XfPal puriﬁcation
The XfPal-enriched inclusion bodies obtained after XfPal over-
expression were used in a protein refolding procedure. The ﬁrst
step of the protein refolding process consisted of washing the
inclusion bodies. The inclusion bodies were resuspended in
20 mL of buffer A containing 1 M urea and sonicated four times
for 50 s at 70% of the maximum power in an ultrasonic homoge-
nizer 4710 (Cole-Parmer Instrument Co.; Chicago, IL, USA),
followed by centrifugation (27,000g for 40 min at 4 C). The inclu-
sion body wash step was repeated three times. Subsequently, the
material collected by centrifugation after the last washing step
was resuspended in 10 mL of buffer A. The total washed inclusion
bodies were divided into two 100 mL beakers and shaken on an
orbital shaker at 30 rpm at room temperature. Each fraction of
the washed inclusion bodies was denatured by adding a freshly
prepared 8 M urea solution dropwise with the aid of a Pasteur pip-
ette until a transparent and homogeneous solution was obtained
(approximately 40 mL of 8 M urea was added to each beaker).
The denatured protein samples were initially dialyzed at a 1:10 ra-
tio against buffer A containing 10% v/v glycerol and 0.1 mM EDTA
(refolding buffer) at 4 C for 4 h. Afterward, another dialysis step
was performed at a 1:100 ratio against the same buffer at 4 C
for 16 h. The solubilized protein sample was recovered by centrifu-
gation (27,000g for 40 min at 4 C). The XfPal protein puriﬁcation
was performed in a single gravity ﬂow chromatography step using
a column packed with 1 mL of Ni–NTA resin (Qiagen; Germany)
equilibrated with buffer A. The puriﬁed XfPal protein was eluted
using a three-step gradient of imidazole (100, 250 and 500 mM)
in buffer A, each step containing 7 mL of the respective buffer.
The purity of the protein samples was estimated by SDS–PAGE
and staining with Coomassie brilliant blue R-250. The total protein
concentration was determined using a micro BCA™ protein assay
kit or by spectroscopy using a calculated molar absorption coefﬁ-
cient at 280 nm (e280) of 16,180 M1/cm for the puriﬁed protein
sample.
Circular dichroism measurements
Circular dichroism (CD) spectra of recombinant XfPal were
collected using a Jasco J-810 Spectropolarimeter dichrograph
(Japan Spectroscopic; Tokyo, Japan). The far-UV CD spectra were
generated at 24 C using the XfPal protein at a concentration of
approximately 6 lM in 10 mM sodium phosphate buffer at pH 8.
The assays were performed using a quartz cuvette with a path
length of 1 mm, and 10 determinations within the range of 270–
190 nm, at a rate of 50 nm/min, were recorded for each sample
and averaged. The deconvolution and statistical analysis of the
CD spectra were performed using the Dichroweb server [23].
Analytical size-exclusion chromatography
For the analytical gel ﬁltration experiments, approximately
1 mg protein samples were loaded into a Superdex 75 10/300 GL
column. After equilibration of the column with buffer A, the pro-
tein sample was loaded at a ﬂow rate of 0.5 mL/min. The Superdex
column was calibrated using HMW and LMW calibration kits as
standard molecular weight markers.
Fig. 2. Steps of the protein refolding protocol and XfPal puriﬁcation. For details on
the refolding protocol, see the ‘Materials and methods’ section. The numbers inside
the parentheses show the protein samples used for the 13.5% SDS–PAGE. XfPal
puriﬁcation was performed using immobilized metal ion afﬁnity chromatography
(IMAC). The puriﬁed XfPal was eluted with seven column volumes of buffer A
containing 100, 250 and 500 mM imidazole. Molecular mass markers (Mw) are
indicated on the right. The predicted weight of recombinant XfPal is 16.8 kDa.
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The E. coli JW0731 strain, a pal-null mutant kindly provided by
the National BioResource Project (NIG Japan), was used for the
peptidoglycan preparation according to the protocol established
by Leduc et al. [24] with minor modiﬁcations. Brieﬂy, cells corre-
sponding to 1 L of culture with an OD600 of 0.8 were suspended in
10 mL of 9% w/v NaCl and then mixed with an equal volume of 8%
w/v sodium dodecyl sulfate (SDS). The suspension was boiled for
30 min at 98 C and, after standing at room temperature overnight,
the sample was centrifuged (27,000g for 1 h at 25 C). The pelleted
material was resuspended in 1 mL of water, washedwith ﬁve cycles
of resuspension and recentrifugation in water, and then resus-
pended in 0.5 mL of 10 mM sodium phosphate buffer, pH 8.
For the in vitro XfPal-peptidoglycan binding assay [18], 4 lg of
the puriﬁed XfPal or a control protein, which has no afﬁnity for
peptidoglycan were centrifuged (27,000g for 1 h at 25 C), and then
the samples were individually incubated with 50 lL of puriﬁed
peptidoglycan (ﬁnal volume, 100 lL) in 10 mM sodium phosphate
buffer (pH 8) containing 150 mMNaCl for 1 h at room temperature.
The mixture was then centrifuged (27,000g for 1 h at 25 C). The
supernatant was collected, and the pellet was washed in 100 lL
of 10 mM sodium phosphate buffer (pH 8) containing 500 mM
NaCl; the wash fraction was collected after centrifugation (as
above). The pellet was resuspended in 40 lL of Laemmli buffer.
The supernatant (S), wash (W), and pellet (P) fractions were sepa-
rated on 13.5% SDS–PAGE. After electrophoresis, the proteins were
transferred to nitrocellulose membranes (Immobilon™-Nc; Sigma)
using a Trans-Blot Semi-Dry Transfer Cell (Bio-Rad; USA) according
to the manufacturer’s instructions. Polyclonal antibodies against
XfPal (or against the control protein) were produced by Rheabio-
tech (Campinas, Brazil) and used in the XfPal-peptidoglycan asso-
ciated assay. The detection of XfPal (or the control protein) was
performed using a 1:8000 dilution of anti-XfPal (or anti-control
protein) and a 1:8000 dilution of anti-rabbit IgG with conjugated
alkaline phosphatase (Santa Cruz Biotechnology Inc.; USA). The
membranes were developed using the NBT/BCIP chromogenic
substrates (Promega; USA).
Results and discussion
Alignment of XfPal with HiPal
The alignment of the XfPal and HiPal precursor amino acid
sequences showed that XfPal is 33 amino acid residues longer than
HiPal (Fig. 1). XfPal and HiPal exhibited a high degree of conserva-
tion, with approximately 41% identity. A signal sequence typical of
lipoprotein precursors, which includes the LVACS motif [1] cleaved
by signal peptidase II during the translocation through the
cytoplasmic membrane, is present in both sequences. Following
the LVACS motif, XfPal contains 17 amino acid residues that are
not found in the HiPal precursor sequence. However, the mature
XfPal was annotated in the X. fastidiosa 9a5c strain genome
database as starting with a methionine residue that is 12 amino
acid residues at the C-terminal of the LVACS motif. The N-terminalFig. 1. ClustalW2 alignment of the amino acid precursor sequences of Pal proteins from
HiPal showed a high degree of conservation, with approximately 41% identity. The regiohydrophobic amino acid residues described as being responsible
for anchoring the outer membrane-like protein in the membrane
[1,2,15,16] are present in the structure of the mature XfPal. In addi-
tion, a high degree of conservation in the C-terminal region, which
is responsible for Pal-peptidoglycan binding [1,3], was observed.XfPal overexpression and protein refolding
The DNA sequence encoding the mature XfPal was successfully
cloned into the pET29a(+) vector. DNA sequencing conﬁrmed that
there was no alteration or base substitution in the sequence of the
positive clone used for the protein overexpression.
In contrast to other studies in which only the soluble periplas-
mic domain of Pal was used for heterologous expression [25,26], in
this study, we also included the N-terminal hydrophobic domain of
XfPal in the expressed protein. Being incorporated into the inclu-
sion bodies, XfPal was found almost entirely in the insoluble frac-
tion. Although, some studies show the solubilization of Pal with
the use of detergents such as SDS, Triton X-100 and deoxycholate
(DOC) [24,27], these detergents were not effective for the solubili-
zation of XfPal. Thus, we developed a new and efﬁcient protein
refolding protocol for XfPal solubilization (Fig. 2). This protocol,
which consisted of an initial step of washing of the XfPal-rich
inclusion bodies with 1 M urea followed by denaturation with
8 M urea (according to a described methodology), allowed the
recovery of approximately 17 mg of puriﬁed XfPal per liter of
bacterial culture. Two steps appear to be crucial for the high efﬁ-
ciency of the protein refolding protocol developed: (1) the denatur-
ation of the inclusion bodies with 8 M urea and (2) the protein
renaturation, consisting of the dialysis steps for removing the urea.
We observed that when the urea solution was added rapidly to
the inclusion bodies, the yield of puriﬁed proteinwas compromised;
with quantities of less than 50% being recovered in comparison toXylella fastidiosa 9a5c strain (XfPal) and Haemophilus inﬂuenzae (HiPal). XfPal and
ns conserved in the two sequences are shown in black.
Table 1
Summary of the yields of the individual steps in the refolding and puriﬁcation of recombinant XfPal from inclusion bodies produced per liter of bacterial culture.
Step Volume (mL) Total proteinc (mg/mL) XfPald (mg) XfPal (%) XfPal purity (%)
Refoldinga
Inclusion bodies, washed 10 11.25 – 100 80
Refolded protein 85 1.47 – – 85
Soluble protein recovered 70 1.46 – – 90
Puriﬁcation by IMACb
Flow-through 65 0.05 0 0 –
Eluate 20 0.87 17.9 22 98
a For details on the protein refolding procedure, see the ‘Materials and methods’ section.
b Immobilized metal ion afﬁnity chromatography.
c Determined using a micro BCA™ protein assay kit.
d Determined spectrophotometrically using a calculated molar absorption coefﬁcient at 280 nm (e280) of 16,180 M1/cm.
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seems to be related to the kinetics of protein denaturation
performed by urea [28] inwhich the constant dripping allows better
protein denaturation. Another critical step was the protein renatur-
ation procedure.We found that glycerol was essential for the stabil-
ization of the hydrophobic regions of XfPal. The dialysis steps in
which this compound was added in quantities less than 10% in the
refolding buffer also compromised the ﬁnal yield of the protein.
It should be noted that despite the fact that mature XfPal con-
tain four cysteine residues no reducing agents were added at any
step of the refolding procedure. Some of these cysteine residues,
especially the cysteines in the N-terminal region, can be modiﬁed
with lipids [1], so that the intrinsic properties of the protein were
not inﬂuenced. More details regarding the yield of XfPal protein
refolding are presented in Table 1.Fig. 3. Circular dichroism spectrum obtained for puriﬁed XfPal. The deconvolution
of the experimental data obtained with the Dichroweb server shows the presence of
approximately 30% a-helices and 15% b-sheets, results similar to those obtained
using the PSIPRED server.XfPal puriﬁcation
After protein solubilization, XfPal was puriﬁed by afﬁnity
chromatography, resulting in approximately 17 mg of puriﬁedXfPal
per liter of bacterial culture (Table 1). The puriﬁed protein has a
predicted mass of 16.8 kDa, corresponding to the 144-amino acid
sequence encoded by ORF Xf1624 plus the C-terminal His6-Tag
added by the pET29a(+) vector. The purity of the protein was
assessed by 13.5% SDS–PAGE (Fig. 2). An interesting feature of the
puriﬁcation step was that XfPal appeared on the stained SDS–PAGE
gel with a mass exceeding 18 kDa, higher than predicted. This fact
can be explained by the presence of covalently linked fatty acids
or other components associated with the protein [29] or simply
by the hydrophobic characteristics of XfPal as analysis by mass
spectrometry conﬁrmed the identity of the recombinant protein
(data not shown).Secondary structure and size-exclusion chromatography analysis
The CD spectrum of puriﬁed XfPal showed that the refolded re-
combinant protein has secondary folding. The CD analysis yielded
spectra characteristic of a protein containing a mixture of a-helix
and b-sheet structures (Fig. 3). The prediction of the secondary
structure for XfPal using the PSIPRED server [30] produced results
similar to those obtained by the deconvolution of the experimental
data obtained by CD, which indicated approximately 30% a-helices
and 15% b-sheets. These results are in accordance with known
elements of secondary structure for XfPal homologs [26].
The oligomeric state of puriﬁed XfPal was analyzed using size-
exclusion chromatography (Fig. 4). Previous studies have shown
that Pal can be found in two distinct forms in the cell envelope:
bound to peptidoglycan or complexed with TolB [18]. A monomer
is often observed for both forms. Samples of refolded XfPal were
eluted in two peaks during gel ﬁltration chromatography assays(Fig. 4A), one with a retention time that corresponds to an appar-
ent molecular weight of 20.8 kDa for (peak 2, Fig. 4B) and the other
with an elution proﬁle typical of a larger oligomer (peak 1). This
pattern, which shows the presence of protein aggregates, has been
observed for other proteins during a refolding protocol [31].
However, using the protocol presented here, a large amount
(approximately 67%) of the protein obtained was in the monomeric
state, an indication of correct folding.XfPal interacts in vitro with puriﬁed peptidoglycan
We assessed the ability of the puriﬁed XfPal to interact in vitro
with peptidoglycan. According to methodology described by Bouv-
eret et al. [18] when puriﬁed peptidoglycan is incubated with
soluble and puriﬁed Pal protein, they can interact in vitro. After
the interaction assay, the protein and peptidoglycan are mostly
observed in the insoluble fraction (pellet) and no protein is
observed in the supernatant. Thus, the interaction is conﬁrmed as
the soluble protein is ‘‘dragged’’ into the pellet fraction by peptido-
glycan. Following this protocol, our experiments show that puriﬁed
XfPal was able to interact with peptidoglycan under the evaluated
conditions, because the protein was no longer observed in the
soluble fraction (S) after incubation with the peptidoglycan and
was only detected in the pellet fraction containing the peptidogly-
can (P) (Fig. 5A). We also used a control protein in this experiment,
with no described afﬁnity for peptidoglycan. In contrast to the
results obtained by Bouveret et al. [18] in which the control protein
was observed only in the soluble fraction (i.e., not interacting with
Fig. 4. Refolded XfPal size-exclusion chromatography analysis. (A) Gel ﬁltration chromatogram of refolded XfPal shows the presence of the XfPal monomer (peak 2) and other
oligomers (peak 1). Protein samples collected for each peak were analyzed by SDS–PAGE and are shown above on the chromatogram. (B) Calibration curve for puriﬁed XfPal.
The expected molecular mass for recombinant XfPal is 16.8 kDa; the estimated molecular weight for XfPal is 20.8 kDa.
Fig. 5. In vitro XfPal-peptidoglycan association assay. Puriﬁed XfPal or control protein was incubated with peptidoglycan as described in the ‘Materials and methods’ section.
After 1 h at room temperature, the samples were centrifuged, and the supernatant (S), wash (W) and pellet (P) fractions were resolved by 13.5% SDS–PAGE. After
electrophoresis, the proteins were transferred to nitrocellulose membranes, and proteins were immunodetected using antibodies against XfPal or the control protein (Ab anti-
XfPal or Ab anti-control). Molecular mass markers (Mw) are indicated on the left.
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present work was observed in the soluble fraction (S), the pellet
containing the peptidoglycan (P) and the wash fraction (W)
(Fig. 5B). This result may be explained by the experimental condi-
tions, as the control protein used in thisworkmay have precipitated
when incubated with the peptidoglycan. This fact was conﬁrmed by
the result of the wash fraction because the control protein was also
detected. In addition, we must also consider the fact that non-
speciﬁc interactions can occur, if the hydrophobic regions of the
control protein interact with the peptidoglycan, which could lead
to the observed results. However, we observed a markedly greater
afﬁnity of XfPal protein for the peptidoglycan (when compared to
our control protein), because XfPal was completely absent from
the soluble fraction andwas only detected in the fraction containing
peptidoglycan, even after the complex XfPal-peptidoglycan had
been subjected to a wash step with 500 mM NaCl.Conclusion
In this work, we developed a new and efﬁcient protein refolding
protocol for the solubilization of recombinant XfPal, which enabled
us to perform an initial characterization of this protein. XfPal was
produced in a large quantity, with the presence of secondary
structure and correct folding, and was able to interact in vitro with
peptidoglycan. In addition, based on our results, we were able to
conﬁrm the prediction of ORF Xf1624 as a peptidoglycan-associated
lipoprotein, as established in the X. fastidiosa genome database.
Bacterial outer membrane proteins, such as Pal, play an impor-
tant role in pathogen-host interactions. Although the study of
these proteins is limited because of the difﬁculties associated with
protein separation and puriﬁcation, such studies have been facili-
tated by improvement of existing techniques and development of
new ones. It is, therefore, of great importance to both reﬁne the
C.A. Santos et al. / Protein Expression and Puriﬁcation 82 (2012) 284–289 289existing methods and develop new techniques that will allow the
study of challenging proteins, particularly membrane proteins.
In this regard, the puriﬁcation protocol reported here is valuable
for further research on the three-dimensional structure and func-
tions of Pal and can contribute to the better understanding of the
role of this protein in bacterial pathogenicity, especially within
the context of the plant pathogen X. fastidiosa.Acknowledgments
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